Chicago IL 超重临床试验
28项针对 超重的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
招募中2 期
- Charter Research LLC - Chicago, Chicago
- Flourish Research - Chicago, Chicago
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Great Lakes Clinical Trials - Ravenswood, Chicago
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Great Lakes Clinical Trials, Chicago
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Chicago Research Center, Inc, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
招募中3 期
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Chicago
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Ann and Robert Lurie Children's Hospital of Chicago, Chicago
- University of Illinois at Chicago, Chicago
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Rush University Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Rush University Medical Center, Chicago
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Great Lakes Clinical Trials - Ravenswood, Chicago
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- Great Lakes Clinical Trials - Ravenswood, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Chicago
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Great Lakes Clinical Trials - Ravenswood, Chicago
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Eagle Clinical Research, Chicago
- University of Chicago, Chicago
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- University Of Chicago, Chicago
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Chicago Research Center, Inc, Chicago
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Great Lakes Clinical Trials - Ravenswood, Chicago
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Flourish Research - Great Lakes Clinical Trials, Chicago
BRIDGE & Friends Trial
招募中欢迎健康志愿者
- University of Illinois Chicago, Chicago
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
招募中欢迎健康志愿者
- Illinois Institute of Technology, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Chicago
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Chicago
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
招募中
- Jesse Brown VA Medical Center, Chicago
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
招募中2 期
- Mile Square Health Center Chicago, Chicago
- Mile Square Health Center - Auburn Gresham, Chicago
- Mile Square Health Center - Englewood, Chicago
- 以及另外 1 项
Better Lifestyle Counseling for African American Women During Pregnancy
招募中
- University of Illinois at Chicago, Chicago
- University of Illinois at Chicago, Chicago
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
招募中观察性研究
- Northwestern Memorial Hospital, Chicago
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
招募中3 期
- University of Chicago, Chicago
其他城市的 超重试验
- Houston, TX33 项研究
- San Antonio, TX33 项研究
- Orlando, FL25 项研究
- Las Vegas, NV23 项研究
- Miami, FL23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- New York City, NY19 项研究
- Austin, TX18 项研究
- Birmingham, AL17 项研究
Chicago的其他研究
- 非小细胞肺癌62 项研究
- 乳腺癌58 项研究
- 癌症（所有类型）53 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肥胖症42 项研究
- 肺癌41 项研究
- 卵巢癌36 项研究
- 卒中35 项研究
- 心力衰竭32 项研究
- 结直肠癌32 项研究
- 急性髓系白血病27 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。